Related Experiment Video
Updated: Jun 13, 2026

Myocardial Infarction by Percutaneous Embolization Coil Deployment in a Swine Model
Published on: November 4, 2021
Embolic infarction associated with cardiac amyloidosis
Kyung-Hee Cho1, Yong Mee Cho, Jong S Kim
1Department of Neurology, University of Ulsan College of Medicine, Asan Medical Center, Seoul, Korea.
Cardiac amyloidosis, a rare condition, can cause embolic cerebral infarction. This study highlights how heart involvement in amyloidosis leads to stroke, emphasizing the need for recognition of this serious complication.
Area of Science:
- Cardiology
- Neurology
- Pathology
Background:
- Embolic cerebral infarction is a serious neurological event.
- Cardiac amyloidosis is a rare infiltrative cardiomyopathy.
- The link between cardiac amyloidosis and cerebral infarction is not well-established.
Purpose of the Study:
- To report cases of embolic cerebral infarction in patients with cardiac amyloidosis.
- To investigate the mechanism linking cardiac amyloidosis to stroke.
- To raise awareness of cardiac amyloidosis as a cause of cardioembolic infarction.
Main Methods:
- Case report of two patients with confirmed amyloidosis.
- Myocardial biopsy for Patient 1 to confirm cardiac amyloidosis.
- Kidney biopsy and echocardiography for Patient 2, revealing characteristic features of cardiac amyloidosis.
Main Results:
- Both patients presented with embolic cerebral infarcts.
- Patient 1: Myocardial biopsy confirmed amyloidosis.
- Patient 2: Kidney biopsy and echocardiography showed granular sparkling, restrictive cardiomyopathy, and mural thrombus, indicative of cardiac amyloidosis.
Conclusions:
- Cardiac amyloidosis can lead to impaired myocardial function and mural thrombosis.
- Mural thrombosis in the heart can result in embolic cerebral infarction.
- Cardiac amyloidosis should be considered a potential cause of cardioembolic stroke.
Related Concept Videos
Amyloid Fibrils
Amyloid deposits were observed as early as 1639 in the liver and the spleen. In 1854, Rudolph Virchow performed iodine staining, normally used to...
Amyloid Fibrils
Amyloid deposits were observed as early as 1639 in the liver and the spleen. In 1854, Rudolph Virchow performed iodine staining, normally used to...
Myocarditis I: Introduction
Cardiomyopathy IV: Restrictive Cardiomyopathy
Cardiomyopathy I: Introduction and Classification
Cardiomyopathy II: Dilated Cardiomyopathy
